Literature DB >> 2571711

Second generation model for prednisolone pharmacodynamics in the rat.

A I Nichols1, F D Boudinot, W J Jusko.   

Abstract

An improved model describing receptor/gene-mediated pharmacodynamics of prednisolone is presented which consists of seven differential equations. Data for plasma prednisolone concentrations, free hepatic glucocorticoid receptors, and hepatic tyrosine aminotransferase activity (TAT) following low (5 mg/kg) and high (50 mg/kg) doses of prednisolone are used to quantitate the kinetics and dynamics of this synthetic steroid in the rat. In contrast to the earlier model, the newer model provides for a coupling and simultaneous fitting of receptor and TAT data and is able to describe the recycling of receptors between cytosol and nucleus and the return of cytosolic receptors to baseline following glucocorticoid elimination. A numerical technique to determine the efficiency of TAT induction based on area under the curve calculations is presented, which supports the hypothesis that nonlinear dose-response effects are due to dose and time-dependent receptor depletion in the cytosol. Simulations are presented to examine the major determinants of corticosteroid effects and to compare the effects of single- and multiple-dose regimens in maximizing drug effects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571711     DOI: 10.1007/BF01059029

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  15 in total

Review 1.  Biochemistry, molecular biology, and physiology of the glucocorticoid receptor.

Authors:  J A Gustafsson; J Carlstedt-Duke; L Poellinger; S Okret; A C Wikström; M Brönnegård; M Gillner; Y Dong; K Fuxe; A Cintra
Journal:  Endocr Rev       Date:  1987-05       Impact factor: 19.871

2.  Methotrexate pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick; D S Zaharko; J A Longstreth
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

Review 3.  Control of gene expression by glucocorticoid hormones.

Authors:  G G Rousseau
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

4.  The acute effects of corticosteroids in bronchial asthma.

Authors:  R Ellul-Micallef
Journal:  Eur J Respir Dis Suppl       Date:  1982

Review 5.  Pharmacokinetic and pharmacodynamic modeling in vivo.

Authors:  N H Holford; L B Sheiner
Journal:  Crit Rev Bioeng       Date:  1981

6.  Dynamics of glucocorticoid receptor and induction of tyrosine aminotransferase in rat liver.

Authors:  M Izawa; A Yoshida; S Ichii
Journal:  Endocrinol Jpn       Date:  1982-04

7.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

8.  Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function.

Authors:  B M Frey; C Walker; F J Frey; A L de Weck
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

9.  Steroid hormone antagonism and a cyclic model of receptor kinetics.

Authors:  A Munck; N J Holbrook
Journal:  J Steroid Biochem       Date:  1987-02       Impact factor: 4.292

10.  Receptor-mediated pharmacodynamics of prednisolone in the rat.

Authors:  F D Boudinot; R D'Ambrosio; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1986-10
View more
  17 in total

1.  Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives.

Authors:  H Derendorf; B Meibohm
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

2.  Corticosteroid-regulated genes in rat kidney: mining time series array data.

Authors:  Richard R Almon; William Lai; Debra C DuBois; William J Jusko
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-06-28       Impact factor: 4.310

Review 3.  Pharmacokinetic-pharmacodynamic modelling: history and perspectives.

Authors:  Chantal Csajka; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-01-11       Impact factor: 2.745

4.  Nonlinear pharmacokinetics and interconversion of prednisolone and prednisone in rats.

Authors:  M L Huang; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

5.  Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.

Authors:  Vivaswath S Ayyar; Siddharth Sukumaran; Debra C DuBois; Richard R Almon; Jun Qu; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-04-27       Impact factor: 2.745

6.  Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.

Authors:  Y N Sun; D C DuBois; R R Almon; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1998-06

Review 7.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

8.  Convergence of direct and indirect pharmacodynamic response models.

Authors:  W J Jusko; H C Ko; W F Ebling
Journal:  J Pharmacokinet Biopharm       Date:  1995-02

9.  Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics.

Authors:  J A Wald; D E Salazar; H Y Chen; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

10.  Inhibition of rat splenocyte proliferation with methylprednisolone: in vivo effect of liposomal formulation.

Authors:  E V Mishina; W J Jusko
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.